Skip to content
10-Q

Quarterly Report

Galileo Life Sciences, Inc.

0001471242-14-000266

← back to feed
Filed
Jul 11, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Jul 9, 2014 75.48M sh
Operating Cash Flow Q2 2014 · Dec 31, 2013 −$453.71K
Operating Cash Flow Q2 2014 · Dec 31, 2012 −$28.15K
Stockholders Equity Q2 2014 · Dec 31, 2013 −$559.64K
Stockholders Equity Q2 2014 · Jun 30, 2013 −$519.77K
Stockholders Equity Q2 2014 · Jun 30, 2012 −$467.17K
Stockholders Equity restated Q2 2014 · Jun 30, 2011 −$103.55K
Stockholders Equity Q2 2014 · Jun 30, 2010 −$4.04K
Stockholders Equity Q2 2014 · Jun 30, 2009 −$1.77K
Stockholders Equity Q2 2014 · Jun 30, 2008 −$1.11K
Current Liabilities Q2 2014 · Dec 31, 2013 $559.64K
Current Liabilities Q2 2014 · Jun 30, 2013 $519.77K
Total Liabilities Q2 2014 · Dec 31, 2013 $559.64K
Total Liabilities Q2 2014 · Jun 30, 2013 $519.77K
Total Assets Q2 2014 · Dec 31, 2013 $0
Total Assets Q2 2014 · Jun 30, 2013 $0
Net Income Q2 2014 · Dec 31, 2013 −$624.9K
Net Income Q2 2014 · Jun 30, 2013 −$52.6K
Net Income Q2 2014 · Dec 31, 2012 −$8.85K
Net Income Q2 2014 · Dec 31, 2012 −$8.85K
Net Income Q2 2014 · Jun 30, 2012 −$363.62K
Net Income restated Q2 2014 · Jun 30, 2011 −$158.28K
Net Income Q2 2014 · Jun 30, 2010 −$8.78K
Net Income Q2 2014 · Jun 30, 2009 −$661
Net Income Q2 2014 · Jun 30, 2008 −$1.11K
Operating Income Q2 2014 · Dec 31, 2013 −$628.19K
Operating Income Q2 2014 · Dec 31, 2012 −$8.85K
Operating Income Q2 2014 · Dec 31, 2012 −$8.85K
Gross Profit Q2 2014 · Dec 31, 2013 $3.41K
Cost Of Revenue Q2 2014 · Dec 31, 2013 $6.1K
Revenue Q2 2014 · Dec 31, 2013 $9.51K